‘‘(1) To expand the availability of physical ac-
tivity programs designed specifically for people with 
arthritis. 
‘‘(2) To provide awareness education to pa-
tients, family members, and health care providers, to 
help such individuals recognize the signs and symp-
toms of arthritis, and to address the control and 
prevention of arthritis. 
‘‘(3) To decrease long-term consequences of ar-
thritis by making information available to individ-
uals with regard to the self-management of arthritis. 
‘‘(4) To provide information on nutrition edu-
cation programs with regard to preventing or miti-
gating the impact of arthritis. 
‘‘(f) EVALUATION.—An eligible entity that receives a 
grant under this section shall submit to the Secretary an 
evaluation of the operations and activities carried out 
under such grant that includes an analysis of increased 
utilization and benefit of public health programs relevant 
to the activities described in the appropriate provisions of 
subsection (e). 
‘‘(g) AUTHORIZATION OF APPROPRIATIONS.—There 
are authorized to be appropriated to carry out this section 
such sums as may be necessary for each of fiscal years 
2006 through 2010.
‘‘SEC. 315D. NATIONAL ARTHRITIS EDUCATION AND OUT-
REACH. 
‘‘(a) IN GENERAL.—The Secretary shall coordinate 
a national education and outreach program to support, de-
velop, and implement education initiatives and outreach 
strategies appropriate for arthritis and other rheumatic 
diseases. 
‘‘(b) INITIATIVES AND STRATEGIES.—Initiatives and 
strategies implemented under the program described in 
paragraph (1) may include public awareness campaigns, 
public service announcements, and community partnership 
workshops, as well as programs targeted at businesses and 
employers, managed care organizations, and health care 
providers. 
‘‘(c) PRIORITY.—In carrying out subsection (a), the 
Secretary—
‘‘(1) may emphasize prevention, early diagnosis, 
and appropriate management of arthritis, and op-
portunities for effective patient self-management; 
and 
‘‘(2) shall give priority to reaching high-risk or 
underserved populations. 
‘‘(d) COLLABORATION.—In carrying out this section, 
the Secretary shall consult and collaborate with stake-
holders from the public, private, and nonprofit sectors
with expertise relating to arthritis control, prevention, and 
treatment. 
‘‘(e) AUTHORIZATION OF APPROPRIATIONS.—There 
are authorized to be appropriated to carry out this section 
such sums as may be necessary for each of fiscal years 
2006 through 2010.’’. 
SEC. 4. EXPANSION AND COORDINATION OF ACTIVITIES OF 
THE NATIONAL INSTITUTES OF HEALTH WITH 
RESPECT TO RESEARCH ON ARTHRITIS. 
Title IV of the Public Health Service Act (42 U.S.C. 
281 et seq.) is amended by inserting after section 439 the 
following: 
‘‘SEC. 439A. ARTHRITIS AND RHEUMATIC DISEASES INTER-
AGENCY COORDINATING COMMITTEE. 
‘‘(a) IN GENERAL.—
‘‘(1) ESTABLISHMENT.—The Secretary shall es-
tablish an Arthritis and Rheumatic Diseases Inter-
agency Coordinating Committee (referred to in this 
section as the ‘Coordinating Committee’). 
‘‘(2) DUTIES.—The coordinating committee es-
tablished under paragraph (1) shall—
‘‘(A) provide for the improved coordination 
of the research activities of all the national re-
search institutes relating to arthritis and rheu-
matic diseases; and
‘‘(B) provide for full and regular commu-
nication and exchange of information necessary 
to maintain adequate coordination across all 
Federal health programs and activities related 
to arthritis and rheumatic diseases. 
‘‘(b) ARTHRITIS AND RHEUMATIC DISEASES INTER-
AGENCY COORDINATING COMMITTEE.—
‘‘(1) COMPOSITION.—The Coordinating Com-
mittee shall consist of members, appointed by the 
Secretary, of which—
‘‘(A) 2⁄3 of such members shall represent 
governmental agencies, including—
‘‘(i) the directors of each of the na-
tional research institutes and divisions in-
volved in research regarding arthritis and 
rheumatic diseases (or the directors’ re-
spective designees); and 
‘‘(ii) representatives of other Federal 
departments and agencies (as determined 
appropriate by the Secretary) whose pro-
grams involve health functions or respon-
sibilities relevant to arthritis and rheu-
matic diseases, including the Centers for 
Disease 
Control 
and 
Prevention, 
the 
Health Resources and Services Administra-
tion, and the Food and Drug Administra-
tion; and 
‘‘(B) 1⁄3 of such members shall be public 
members, including a broad cross section of 
persons affected by arthritis, researchers, clini-
cians, and representatives of voluntary health 
agencies, who—
‘‘(i) shall serve for a term of 3 years; 
and 
‘‘(ii) may serve for an unlimited num-
ber of terms if reappointed. 
‘‘(2) CHAIRPERSON.—
‘‘(A) APPOINTMENT.—The Chairperson of 
the Coordinating Committee (referred to in this 
subsection as the ‘Chairperson’) shall be ap-
pointed by and be directly responsible to the 
Secretary. 
‘‘(B) DUTIES.—The Chairperson shall—
‘‘(i) serve as the principal advisor to 
the Secretary, the Assistant Secretary for 
Health, and the Director of NIH on mat-
ters relating to arthritis and rheumatic dis-
eases; and 
‘‘(ii) provide advice to the Director of 
the Centers for Disease Control and Pre-
vention, the Commissioner of Food and 
Drugs, and the heads of other relevant 
Federal agencies, on matters relating to 
arthritis and rheumatic diseases. 
‘‘(3) ADMINISTRATIVE SUPPORT; MEETINGS.—
‘‘(A) 
ADMINISTRATIVE
SUPPORT.—The 
Secretary shall provide necessary and appro-
priate administrative support to the Coordi-
nating Committee. 
‘‘(B) MEETINGS.—The Coordinating Com-
mittee shall meet on a regular basis as deter-
mined by the Secretary, in consultation with the 
Chairperson. 
‘‘(c) ARTHRITIS AND RHEUMATIC DISEASES SUM-
MIT.—
‘‘(1) IN GENERAL.—Not later than 1 year after 
the date of enactment of the Arthritis Prevention, 
Control, and Cure Act of 2005, the Coordinating 
Committee shall convene a summit of researchers, 
public health professionals, representatives of vol-
untary health agencies, representatives of academic 
institutions, and Federal and State policymakers, to 
provide a detailed overview of current research ac-
tivities at the National Institutes of Health, as well 
as to discuss and solicit input related to potential
areas of collaboration between the National Insti-
tutes of Health and other Federal health agencies, 
including the Centers for Disease Control and Pre-
vention, the Agency for Healthcare Research and 
Quality, and the Health Resources and Services Ad-
ministration, related to research, prevention, and 
treatment of arthritis and rheumatic diseases. 
‘‘(2) SUMMIT DETAILS.—The summit developed 
under paragraph (1) shall focus on—
‘‘(A) a broad range of research activities 
relating to biomedical, epidemiological, psycho-
social, and rehabilitative issues, including stud-
ies of the impact of the diseases described in 
paragraph (1) in rural and underserved commu-
nities; 
‘‘(B) clinical research for the development 
and evaluation of new treatments, including 
new biological agents; 
‘‘(C) translational research on evidence-
based and cost-effective best practices in the 
treatment, prevention, and management of the 
disease; 
‘‘(D) information and education programs 
for health care professionals and the public;
‘‘(E) priorities among the programs and 
activities of the various Federal agencies re-
garding such diseases; and 
‘‘(F) challenges and opportunities for sci-
entists, clinicians, patients, and voluntary orga-
nizations. 
‘‘(d) REPORT TO CONGRESS.—Not later than 180 
days after the convening of the Arthritis and Rheumatic 
Diseases Summit under subsection (c)(1), the Director of 
NIH shall prepare and submit a report to Congress that 
includes proceedings from the summit and a description 
of arthritis research, education, and other activities that 
are conducted or supported through the national research 
institutes. 
‘‘(e) 
PUBLIC
INFORMATION.—The 
Coordinating 
Committee shall make readily available to the public infor-
mation about the research, education, and other activities 
relating to arthritis and other rheumatic diseases, con-
ducted or supported by the National Institutes of Health. 
‘‘(f) AUTHORIZATION OF APPROPRIATIONS.—There 
are authorized to be appropriated such sums as may be 
necessary for each of fiscal years 2006 through 2010 to 
carry out this section.’’.
SEC. 5. EXPANSION, INTENSIFICATION, AND INNOVATION 
OF RESEARCH AND PUBLIC HEALTH ACTIVI-
TIES RELATED TO JUVENILE ARTHRITIS. 
(a) JUVENILE ARTHRITIS INITIATIVE THROUGH THE 
DIRECTOR OF THE NATIONAL INSTITUTES OF HEALTH.—
Part A of title IV of the Public Health Service Act (42 
U.S.C. 281 et seq.) is amended by adding at the end the 
following: 
‘‘SEC. 404H. JUVENILE ARTHRITIS INITIATIVE THROUGH 
THE DIRECTOR OF THE NATIONAL INSTI-
TUTES OF HEALTH. 
‘‘(a) EXPANSION AND INTENSIFICATION OF ACTIVI-
TIES.—
‘‘(1) IN GENERAL.—The Director of NIH, in 
coordination with the Director of the National Insti-
tute of Arthritis and Musculoskeletal and Skin Dis-
eases, and the directors of the other national re-
search institutes, as appropriate, shall expand and 
intensify programs of the National Institutes of 
Health with respect to research and related activities 
concerning various forms of juvenile arthritis. 
‘‘(2) COORDINATION.—The directors referred to 
in paragraph (1) shall jointly coordinate the pro-
grams referred to in such paragraph and consult 
with additional Federal officials, voluntary health as-
sociations, medical professional societies, and private 
entities as appropriate. 
‘‘(b) PLANNING GRANTS AND CONTRACTS FOR INNO-
VATIVE RESEARCH IN JUVENILE ARTHRITIS.—
‘‘(1) IN GENERAL.—In carrying out subsection 
(a)(1) the Director of NIH shall award planning 
grants or contracts for the establishment of new re-
search programs, or enhancement of existing re-
search programs, that focus on juvenile arthritis. 
‘‘(2) RESEARCH.—
‘‘(A) TYPES OF RESEARCH.—In carrying 
out this subsection, the Secretary shall encour-
age research that focus on genetics, on the de-
velopment of biomarkers, and on pharma-
cological and other therapies. 
‘‘(B) PRIORITY.—In awarding planning 
grants or contracts under paragraph (1), the 
Director of NIH may give priority to collabo-
rative partnerships, which may include aca-
demic health centers, private sector entities, 
and nonprofit organizations. 
‘‘(c) AUTHORIZATION OF APPROPRIATIONS.—There 
are authorized to be appropriated such sums as may be 
necessary for each of fiscal years 2006 through 2010 to 
carry out this section. Such authorization shall be in addi-
tion to any authorization of appropriations under any 
other provision of law to carry out juvenile arthritis activi-
ties or other arthritis-related research.’’. 
(b) PUBLIC HEALTH AND SURVEILLANCE ACTIVI-
TIES RELATED TO JUVENILE ARTHRITIS AT THE CEN-
TERS FOR DISEASE CONTROL AND PREVENTION.—Part 
B of title III of the Public Health Service Act (42 U.S.C. 
243 et seq.) is amended by inserting after section 320A 
the following: 
‘‘SEC. 320B. SURVEILLANCE AND RESEARCH REGARDING 
JUVENILE ARTHRITIS. 
‘‘(a) IN GENERAL.—The Secretary, acting through 
the Director of the Centers for Disease Control and Pre-
vention, may award grants to and enter into cooperative 
agreements with public or nonprofit private entities for the 
collection, analysis, and reporting of data on juvenile ar-
thritis. 
‘‘(b) TECHNICAL ASSISTANCE.—In awarding grants 
and entering into agreements under subsection (a), the 
Secretary may provide direct technical assistance in lieu 
of cash. 
‘‘(c) COORDINATION WITH NIH.—The Secretary 
shall ensure that epidemiological and other types of infor-
mation obtained under subsection (a) is made available to 
the National Institutes of Health.
‘‘(d) CREATION OF A NATIONAL JUVENILE ARTHRI-
TIS PATIENT REGISTRY.—The Secretary, acting through 
the Director of the Centers for Disease Control and Pre-
vention and in collaboration with a national voluntary 
health organization with experience serving the juvenile 
arthritis population as well as the full spectrum of arthri-
tis-related conditions, shall support the development of a 
National Juvenile Arthritis Patient Registry to collect spe-
cific data for follow-up studies regarding the prevalence 
and incidence of juvenile arthritis, as well as capturing 
information on evidence-based health outcomes related to 
specific therapies and interventions. 
‘‘(e) AUTHORIZATION OF APPROPRIATIONS.—There 
are authorized to be appropriated such sums as may be 
necessary to carry out this section.’’. 
SEC. 
6. 
INVESTMENT 
IN 
TOMORROW’S 
PEDIATRIC 
RHEUMATOLOGISTS. 
(a) IN GENERAL.—Part Q of title III of the Public 
Health Service Act (42 U.S.C. 280h et seq.) is amended 
by adding at the end the following: 
‘‘SEC. 399AA. INVESTMENT IN TOMORROW’S PEDIATRIC 
RHEUMATOLOGISTS. 
‘‘(a) ENHANCED SUPPORT.—In order to ensure an 
adequate future supply of pediatric rheumatologists, the 
Secretary, in consultation with the Administrator of the
Health Resources and Services Administration, shall sup-
port activities that provide for—
‘‘(1) an increase in the number and size of in-
stitutional training grants awarded to institutions to 
support pediatric rheumatology training; and 
‘‘(2) an expansion of public-private partnerships 
to encourage academic institutions, private sector 
entities, and health agencies to promote educational 
training and fellowship opportunities for pediatric 
rheumatologists. 
‘‘(b) AUTHORIZATION.—There are authorized to be 
appropriated such sums as may be necessary for each of 
fiscal years 2006 through 2010 to carry out this section.’’. 
(b) PEDIATRIC LOAN REPAYMENT PROGRAM.—Part 
Q of title III of the Public Health Service Act (42 U.S.C. 
280h et seq.), as amended by subsection (a), is further 
amended by adding at the end the following: 
‘‘SEC. 399BB. PEDIATRIC RHEUMATOLOGY LOAN REPAY-
MENT PROGRAM. 
‘‘(a) IN GENERAL.—The Secretary, in consultation 
with the Administrator of the Health Resources and Serv-
ices 
Administration, 
may 
establish 
a 
pediatric 
rheumatology loan repayment program.
‘‘(b) PROGRAM ADMINISTRATION.—Through the pro-
gram established under subsection (a), the Secretary 
shall—
‘‘(1) enter into contracts with qualified health 
professionals who are pediatric rheumatologists 
under which—
‘‘(A) such professionals agree to provide 
health care in an area with a shortage of pedi-
atric rheumatologists; and 
‘‘(B) the Federal Government agrees to 
repay, for each year of such service, not more 
than $25,000 of the principal and interest of 
the educational loans of such professionals; and 
‘‘(2) in addition to making payments under 
paragraph (1) on behalf of an individual, make pay-
ments to the individual for the purpose of providing 
reimbursement for tax liability resulting from the 
payments made under paragraph (1), in an amount 
equal to 39 percent of the total amount of the pay-
ments made for the taxable year involved. 
‘‘(c) FUNDING.—
‘‘(1) IN
GENERAL.—For the purpose of car-
rying out this section, the Secretary may reserve, 
from amounts appropriated for the Health Re-
sources and Services Administration for the fiscal
year involved, such amounts as the Secretary deter-
mines to be appropriate. 
‘‘(2) AVAILABILITY OF FUNDS.—Amounts made 
available to carry out this section shall remain avail-
able until the expiration of the second fiscal year be-
ginning after the fiscal year for which such amounts 
were made available.’’. 
SEC. 7. CAREER DEVELOPMENT AWARDS IN PEDIATRIC 
RHEUMATOLOGY. 
Part G of title IV of the Public Health Service Act 
(42 U.S.C. 288 et seq.) is amended—
(1) by redesignating section 487F (as added by 
Public Law 106–310) as section 487G; 
(2) by inserting after section 487G (as so re-
designated) the following: 
‘‘SEC. 487H. CAREER DEVELOPMENT AWARDS IN PEDI-
ATRIC RHEUMATOLOGY. 
‘‘(a) IN GENERAL.—The Secretary, in consultation 
with the Director of NIH, may establish a program to in-
crease the number of career development awards for 
health professionals who intend to build careers in clinical 
and 
translational 
research 
relating 
to 
pediatric 
rheumatology.
‘‘(b) AUTHORIZATION OF APPROPRIATIONS.—There 
are appropriated such sums as may be necessary to carry 
out this section.’’. 
SEC. 8. GENERAL ACCOUNTING OFFICE STUDY OF ARTHRI-
TIS AND THE WORKPLACE. 
(a) STUDY AND REPORT.—Not later than 3 years 
after the date of enactment of this Act, the Comptroller 
General of the United States shall conduct a study on the 
economic impact of arthritis in the workplace, and submit 
a report to the appropriate committees of Congress con-
taining the results of the study. 
(b) AUTHORIZATION
OF APPROPRIATIONS.—There 
are authorized to be appropriated such sums as may be 
necessary to carry out this section.
Æ